The BMJ is an international peer reviewed medical journal and a fully “online first” publication. The BMJ’s vision is to be the world’s most influential and widely read medical journal. Our mission is to lead the debate on health and to engage, inform, and stimulate doctors, researchers, and other health professionals in ways that will improve outcomes for patients. We aim to help doctors to make better decisions.
Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
Manage episode 282383106 series 1475919
Player FM과 저희 커뮤니티의 CancerCare 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.
* What’s New from SABCS on: ER, PR and HER2 Positive Breast Cancer, in the Context of COVID-19 * Updates from SABCS on Diagnostic Testing, Precision Medicine, Grade & Hormone Receptors * What’s New in the Standard of Care * Updates from SABCS on: Hormone & Targeted Therapy * Chemotherapy Updates from SABCS * Investigational New Drugs in Clinical Trials * What’s New in Prevention & Management of Treatment Side Effects & Long Term Effects * The Increasing Role of Telemedicine/Telehealth Appointments * Proper Preparation for the Telemedicine/Telehealth Appointments * Key Questions from SABCS to Ask Your Healthcare Team about Quality-of-Life Concerns * Questions for Our Panel of Experts